3Sedor IR, kenieczkowski M, Huang S, et al. Cytokines in mesan-gial cell activation and glomerular injury[J].Kidney Int,1993,43: 64-65.
4BauI L,Fouqueray B,Philippe C, et al.Kidney Int,1992,41: 600-603.
5Hasegawa G,Nakano K,Sawada M,et al.Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction[J]. Possible role of necrosis factor and interleukin-I in the development of diabetic nephropathy[J]. Kidney Int, 1991,40 (6): 1007-1012.
6Navarro JF, Mora C, Rivero A, et al. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration[J]. Am J Kidney Dis, 1999,33: 458-463.
二级参考文献21
1Lechleitner M, Koch T, Herold M, et al. Tumor necrosis factor alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and card-iovascular risk factors[J] .J Intern Med,2000,248:67-76.
2John C P, Gary D C, Stephen M T, et al. Plasma interleu-kin 6, tumor necrosis factor α and blood cytokine production in type 2 diabetes[J]. Life Sci,2000,67:291-300.
3Pfeiffer A, Janott J, Mohlig M, et al. Circulating tumor ne-crosis factor α is elevated in male but not in female patients with type Ⅱ diabetes mellitus [ J]. Horm Metab Res, 1997,29:111-114.
4Hellmich B, Schellner M, Schatz H, et al. Activation of transforming growth factor β in diabetic kidney disease[J].Metabolism, 2000,49: 355-359.
5Alessandro A, Paola C, Stefania M, et al. Nonenzymatically glycated albumin(Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells[J]. Kidney Int, 1997,51:27-35.
6Sugimoto H, Shikata K, Wada J, et al. Advanced glycation endproducts-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the over expression of tumour necrosis factor α and inducible nitric oxide synthase in diabetic rat glomeruli[J].Diabetologia, 1999,42: 878-886.
7Ohmori M, Harada K, Kitoh Y, et al. The functions of circulatory polymorphonuclear leukocytes in diabetic patients with and without diabetic triopathy [J]. Life Sci, 2000,66:1861-1870.
8Fournier T, Fadok V, Henson P, et al. Tumor necrosis factor alpha inversely regulates prostaglandin D2 and pros-taglandin E2 production in murine nacrophages, synergistic action of cyclic AMP on cyclooxygenase 2 expression and prostaglandin E2 synthesis[J]. J Biol Chem, 1997,272: 31-65.
9Huang Z, Massey J, Via D, et al. Differential regulation of cyclooxygenase 2 (COX 2)mRNA stability by interleukin 1 beta(IL l beta) and tumor necrosis factor alpha(TNF alpha)in human in vitro differentiated macrophages [J]. Biochem Pharmacol, 2000,59: 187-194.
10Furuta I, Yamada H, Sagawa T, et al. Effects of inflammatory cytokines on prostaglandin E(2) production from human amnion cells cultured in serum free condition [ J ]. Gynecol Obstet Invest, 2000,49: 93-97.
